NO157175C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner. - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.

Info

Publication number
NO157175C
NO157175C NO820686A NO820686A NO157175C NO 157175 C NO157175 C NO 157175C NO 820686 A NO820686 A NO 820686A NO 820686 A NO820686 A NO 820686A NO 157175 C NO157175 C NO 157175C
Authority
NO
Norway
Prior art keywords
aroylimidazolons
preparation
therapeutically active
analogy procedure
analogy
Prior art date
Application number
NO820686A
Other languages
English (en)
Other versions
NO820686L (no
NO157175B (no
Inventor
Richard C Dage
Frank P Palopoli
Richard A Schnettler
J Martin Grisar
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO820686L publication Critical patent/NO820686L/no
Publication of NO157175B publication Critical patent/NO157175B/no
Publication of NO157175C publication Critical patent/NO157175C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
NO820686A 1981-03-05 1982-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner. NO157175C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (3)

Publication Number Publication Date
NO820686L NO820686L (no) 1982-09-06
NO157175B NO157175B (no) 1987-10-26
NO157175C true NO157175C (no) 1988-02-03

Family

ID=26933806

Family Applications (1)

Application Number Title Priority Date Filing Date
NO820686A NO157175C (no) 1981-03-05 1982-03-04 Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.

Country Status (18)

Country Link
US (1) US4405628A (no)
EP (1) EP0059948B1 (no)
KR (1) KR890000765B1 (no)
AT (1) ATE16489T1 (no)
AU (1) AU557590B2 (no)
CA (1) CA1190550A (no)
DE (1) DE3267352D1 (no)
DK (1) DK168627B1 (no)
ES (2) ES510087A0 (no)
GB (1) GB2096600B (no)
GR (1) GR76518B (no)
HK (1) HK61686A (no)
IE (1) IE52387B1 (no)
IL (1) IL65137A (no)
MY (1) MY8600700A (no)
NO (1) NO157175C (no)
NZ (1) NZ199885A (no)
PH (1) PH18345A (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
CA1262732C (en) * 1984-07-30 1989-11-07 PREPARATION OF 1,3-DIHYDRO-4-PYRIDOYL-2H-IMIDAZOL-2-ONES
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
CA3089569C (en) 2007-06-04 2023-12-05 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN108676076A (zh) 2011-03-01 2018-10-19 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
EP2970384A1 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
WO2015021358A2 (en) 2013-08-09 2015-02-12 Dominique Charmot Compounds and methods for inhibiting phosphate transport
JP2022533251A (ja) 2019-05-21 2022-07-21 アルデリックス， インコーポレイテッド 患者において血清リン酸塩を低下させるための組み合わせ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
GB2096600A (en) 1982-10-20
NZ199885A (en) 1985-04-30
MY8600700A (en) 1986-12-31
ES8305352A1 (es) 1983-04-16
ES510087A0 (es) 1983-04-16
HK61686A (en) 1986-08-29
GR76518B (no) 1984-08-10
CA1190550A (en) 1985-07-16
EP0059948B1 (en) 1985-11-13
IE52387B1 (en) 1987-10-14
AU557590B2 (en) 1986-12-24
IE820491L (en) 1982-09-05
ATE16489T1 (de) 1985-11-15
ES519254A0 (es) 1984-03-01
NO820686L (no) 1982-09-06
IL65137A (en) 1987-02-27
DK168627B1 (da) 1994-05-09
EP0059948A1 (en) 1982-09-15
NO157175B (no) 1987-10-26
IL65137A0 (en) 1982-05-31
GB2096600B (en) 1985-06-05
KR830009046A (ko) 1983-12-17
AU8103782A (en) 1982-09-09
DE3267352D1 (en) 1985-12-19
PH18345A (en) 1985-06-05
KR890000765B1 (ko) 1989-04-05
ES8402827A1 (es) 1984-03-01
DK95482A (da) 1982-09-06
US4405628A (en) 1983-09-20

Similar Documents

Publication Publication Date Title
NO157175C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive aroylimidazoloner.
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
NO800858L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-amino-3-kinolincarboxylsyrederivater
NO151966C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazol-5-eddiksyrederivater
NO156611C (no) Analogifremgangsmaate for fremstilling av terapeutiske virksomme derivater av hydroksykarbonylfosfonsyre.
DK103384D0 (da) Quinoloncarboxylsyrer eller salte eller hydrater deraf, deres fremstilling og anvendelse som antibakterielle midler
NO166939C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater.
FI854926A (fi) Foerfarande foer framstaellning av farmakologiskt aktiva pyrrolobensimidazoler.
JPS57122085A (en) Circulatory disease extirpenter and use
NO166863C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-substituert-1,2-dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carboxylsyrer ut fra deres tilsvarende nitriler.
NO152089C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-pyridon-3-karboksylsyrederivater
NO864514D0 (no) Fremgangsmaate for fremstilling av thiazoloner.
NO156900C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater.
NO148451C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive oximethere
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
NO164599C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt 7-d-mandelamido-3-(1-sulfometyl-tetrazol-5-yl)-tiometyl-3-cefem-4-karboksylsyre-mononatriumsalt.
NO150080C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-amino-3-(alkylthiobenzoyl)-fenyleddiksyrederivater
GB1527479A (en) Acid addition salts of d-(+)-1-(3-hydroxyphenyl)-2-aminopropane and their manufacture and use
NO149350C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiopropanoylaminosyrederivater
NO156651C (no) Analogifremgangsmaate for fremstilling av forbindelser egnet for behandling eller profylakse av hjertesykdommer.